Description

Ethyl 2-[(3,4-Dimethoxybenzoyl)Amino]-5,5-Dimethyl-4,7-Dihydro-5H-Thieno[2,3-C]Pyran-3-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in medicinal chemistry for its role as a key building block in the synthesis of novel therapeutic agents. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities, particularly for central nervous system and metabolic disorder targets.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of proprietary drug candidates, especially those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new pharmacophores with enhanced efficacy and selectivity.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core scaffold in the development of potential APIs for neurological and psychiatric disorders.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for clinical trial material.
• Biochemical Research: Employed as a tool compound in biochemical assays to study receptor binding and cellular signaling mechanisms.

Basic Information

Product Name	Ethyl 2-[(3,4-Dimethoxybenzoyl)Amino]-5,5-Dimethyl-4,7-Dihydro-5H-Thieno[2,3-C]Pyran-3-Carboxylate
CAS No.	305375-45-5
Molecular Formula	C21H25NO6S
Molecular Weight	419.49 g/mol
Synonyms	Ethyl 2-[(3,4-dimethoxybenzoyl)amino]-5,5-dimethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate; 5H-Thieno[2,3-c]pyran-3-carboxylic acid, 2-[(3,4-dimethoxybenzoyl)amino]-5,5-dimethyl-4,7-dihydro-, ethyl ester; 305375-45-5; UNII-8W2X8T4Q4K; 8W2X8T4Q4K; SCHEMBL218422; AOB34017
EINECS	Contact for details

Quality Control

Our Ethyl 2-[(3,4-Dimethoxybenzoyl)Amino]-5,5-Dimethyl-4,7-Dihydro-5H-Thieno[2,3-C]Pyran-3-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep container tightly sealed in a dry environment to minimize moisture uptake.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.